[Psychedelics in the treatment of PTSD]
Vermetten, E., Krediet, E., Bostoen, T., Breeksema, J. J., Schoevers, R. A., & van den Brink, W. | Tijdschrift Voor Psychiatrie |1 August 2020
The Current Status of Psychedelics in Psychiatry
Nutt, D., & Carhart-Harris, R. | JAMA psychiatry | 29 July 2020
LSD-induced increases in social adaptation to opinions similar to one’s own are associated with stimulation of serotonin receptors
Duerler, P., Schilbach, L., Stämpfli, P., Vollenweider, F. X., & Preller, K. H. | Scientific reports | 22 July 2020
Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms
Morita, I., Oyama, H., Kiguchi, Y., Oguri, A., Fujimoto, N., Takeuchi, A., ... & Kobayashi, N. | Journal of Pharmaceutical and Biomedical Analysis | 21 July 2020
Ibogaine therapy for addiction: Consumer views from online fora
Barber, M., Gardner, J., Savic, M., & Carter, A. | Journal of Drug Policy | 18 July 2020
Perceived harm, motivations for use and subjective experiences of recreational psychedelic ‘magic’ mushroom use
Roberts, C. A., Osborne-Miller, I., Cole, J., Gage, S. H., & Christiansen, P. | Journal of Psychopharmacology| 17 July 2020
Psychedelic Research and the Need for Transparency: Polishing Alice’s Looking Glass
Petranker, R., Anderson, T., & Farb, N. | Frontiers in psychology | 10 July 2020
The pharmacological interaction of compounds in ayahuasca: a systematic review
Ruffell, S., Netzband, N., Bird, C., Young, A. H., & Juruena, M. F. | Brazilian Journal of Psychiatry | 03 July 2020
Synthesis and characterization of high-purity N,N-dimethyltryptamine hemifumarate for human clinical trials
Cozzi, N. V., & Daley, P. F. | Drug Testing and Analysis | 01 July 2020
Benefit-Risk Assessment of Esketamine Nasal Spray vs. Placebo in Treatment-Resistant Depression
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., ... & Stahl, S. | American Journal of Psychiatry | 1 February 2020